FindTrial
Sign In

The study on the pathogensis of patients with Henoch-Scheonlein Purpura based on the structural abnormalities of IgA1

The study on the pathogensis of patients with Henoch-Scheonlein Purpura based on the structural abnormalities of IgA1

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-COC-15006255
Enrollment
Unknown
Registered
2015-04-14
Start date
2015-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Henoch-Schonlein Purpura

Interventions

HSP group:no
control group:no

Sponsors

Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 18 Years

Inclusion criteria

Inclusion criteria: Palpable purpura (mandatory criterion) in the presence of at least one of the following four features: Diffuse abdominal pain; Any biopsy showing predominant IgA deposition; Arthritis* or arthralgia ; Renal involvement (any haematuria and/or proteinuria).

Exclusion criteria

Exclusion criteria: exclude all other diseases that can produce similar symptoms, such as Idiopathic thrombocytopenic purpura, intussusception, andjoint disease with joint symptoms.

Design outcomes

Primary

MeasureTime frame
mRNA expression of beta - 1, 3 - galactosyl transferase;—

Countries

China

Contacts

Public ContactJin Yanliang
jinyanliang2000@163.com+86 13501622815

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026